Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,132Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M3.1EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book5.210-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.5PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34,850,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XBI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
XBIFirst Eagle Investment 2016-03-31 Buy $45.73 - $70.2
$ 61.1917%New holding18,150
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XBI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

XBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Element, MartynDirector 2016-08-08Buy10,000$0.1540693.33view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell200$12.1405.7view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell1,800$12.1405.7view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell2,000$12.11405.28view
Ghuldu, RishiSenior Officer 2016-08-08Sell149$23.45160.94view
Louis, PeterSenior Officer 2016-08-08Sell5,000$87.86-30.36view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy5,000$1.73499.41view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy4,700$1.653608.48view
Kovacevic, John GianniDirector, Senior Officer 2016-08-08Buy200,000$0.0876387.5view
Espaillat Lamarche, Julio ErneSenior Officer 2016-08-08Sell190,000$0.610098.33view

Quarterly/Annual Reports about XBI:

    News about XBI:

    Articles On GuruFocus.com
    Value Investing in BioPharma Nov 18 2015 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    Biotech Stocks: Look Who's Selling Aug 29 2016
    Biotech ETFs in Focus After Mylan's EpiPen Controversy Aug 26 2016
    Could Zinbryta Become a Novel Immunomodulatory Therapy for MS? Aug 26 2016
    How Advisors Evaluate Industry, Sector ETFs Aug 24 2016
    Medivation: The Latest Analyst Recommendations Aug 24 2016
    It Could Be An Interesting Ride For Healthcare ETFs Aug 23 2016
    Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts Aug 22 2016
    Healthcare Investors May Be Pricing In A Clinton Victory Aug 17 2016
    Charting the U.S. benchmarks’ pulling-teeth breakout attempt Aug 16 2016
    Tuesday links: operating in silos Aug 16 2016
    US Consumer Sentiment Is Below the Forecast Aug 16 2016
    Bulls are chasing uptrend in biotech fund Aug 15 2016
    Biotech Stocks: The Rebirth of the Bull? Aug 15 2016
    Active Traders Turn Bullish on Biotech Aug 11 2016
    Crushed Bio-Tech leader falls 90%, now attempting breakout Aug 09 2016
    The Week Ahead: Is Macro Really Wacko? Aug 06 2016
    Why Markets Remained Range Bound after US Data Release Aug 05 2016
    Biogen surges on takeover talk. 4 Trades Aug 02 2016
    2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You? Aug 02 2016
    Is BioMarin Set to Become Profitable in 2017? Aug 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)